In the TME of ovarian cancer, the ratio of CD8+ T cells to Foxp3+ regulatory T cells was significantly high, which was associated with a particularly favorable prognosis (Curiel et al., 2004). The gene discussed is CD8A; the disease is ovarian carcinoma.